Posted on December 8th, 2011 by
Lawyers for Minnesota's Mayo Clinic will appear before the justices of the U.S. Supreme Court Wednesday morning to argue that patents underlying a blood test are too broad and inhibit doctors from treating patients. In a case that could have big implications for patent law, the high court will weigh whether the clinic infringed upon a patent held by Prometheus Labs San Diego.
MPR, by Brett Neely, 12/6/11
Additional coverage: Wall Street Journal, MPR Daily Digest, KAAL, Genetic Engineering & Biotechnology, Fierce Healthcare, UK ADVFN, London Stock Exchange, Middle Eastern Financial Network, Toronto Telegraph
You must be logged-in to the site to post a comment.